Lamdong Pharmaceutical JSC (HNX:LDP)
Vietnam · Delayed Price · Currency is VND 7,700.00
+100.00 (1.32%)
At close: Nov 3, 2026
HNX:LDP Financials Overview
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 278,166 | 243,906 | 217,958 | 186,001 | 187,415 | 161,902 |
Revenue Growth | 15.00% | 11.91% | 17.18% | -0.75% | 15.76% | -57.36% |
Gross Profit Gross Profit Growth | 97,829 | 81,232 | 64,390 | 37,166 | 37,519 | 21,225 |
Operating Income Operating Income Growth | 28,094 | 17,460 | 13,280 | -12,347 | -25,314 | -19,788 |
Net Income Net Income Growth | 28,591 | 28,558 | 6,919 | -20,105 | -38,891 | 37,870 |
Earnings Per Share EPS Growth | 1579.10 | 2029.81 | 544.66 | -1583.00 | -3062.00 | 2981.00 |
EPS Growth | 128.41% | 272.67% | - | - | - | 143.55% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Others Others Growth | 2,804 | 2,410 | 2,497 |
Trading Trading Growth | 80,966 | 85,637 | 85,427 |
Manufacture Manufacture Growth | 160,136 | 129,911 | 98,077 |
Total Total Growth | 243,906 | 217,958 | 186,001 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 19,447 | 20,829 | 17,157 | 20,222 | 18,407 | 65,159 |
Total Debt Total Debt Growth | 58,761 | 56,974 | 55,026 | 65,960 | 70,889 | 32,299 |
Net Cash (Debt) Net Cash Growth | -39,314 | -36,145 | -37,869 | -45,738 | -52,482 | 32,860 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2171.36 | -2569.07 | -2981.06 | -3600.54 | -4132.07 | 2586.61 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 8,091 | 3,452 | 8,766 | 6,036 | -44,803 | 29,077 |
Capital Expenditures CapEx Growth | -63,039 | -63,046 | -2,930 | -59.05 | -1,916 | -7,685 |
Free Cash Flow Free Cash Flow Growth | -54,948 | -59,594 | 5,835 | 5,977 | -46,718 | 21,392 |
Free Cash Flow Growth | - | - | -2.37% | - | - | 1789.48% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 35.17% | 33.30% | 29.54% | 19.98% | 20.02% | 13.11% |
Operating Margin | 10.10% | 7.16% | 6.09% | -6.64% | -13.51% | -12.22% |
Pretax Margin | 11.84% | 11.77% | 3.17% | -10.81% | -20.73% | 25.15% |
Profit Margin | 10.28% | 11.71% | 3.17% | -10.81% | -20.75% | 23.39% |
FCF Margin | -19.75% | -24.43% | 2.68% | 3.21% | -24.93% | 13.21% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.88 | 5.18 | 18.73 | - | - | 12.58 |
P/FCF Ratio | - | - | 22.21 | 33.79 | - | 22.27 |
PS Ratio | 0.51 | 0.61 | 0.59 | 1.09 | 0.35 | 2.94 |